Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab

The identification of prognostic and predictive biomarkers for high-programmed cell death-ligand 1 (PD-L1) advanced non-small cell lung cancer (aNSCLC) treated with first-line pembrolizumab could support the decision-making about possible combination therapies. To explore the baseline neutrophil-to-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Lung Cancer Res
Autors principals: Banna, Giuseppe Luigi, Signorelli, Diego, Metro, Giulio, Galetta, Domenico, De Toma, Alessandro, Cantale, Ornella, Banini, Marco, Friedlaender, Alex, Pizzutillo, Pamela, Garassino, Marina Chiara, Addeo, Alfredo
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2020
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481583/
https://ncbi.nlm.nih.gov/pubmed/32953525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-19-583
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars